oral semaglutide cardiovascular benefit 50 mg of #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Oral Semaglutide and Cardiovascular Outcomes

Extreme weight loss in a short period of time with or without GLP-1s can cause a loss of skin elasticity due to the disruption of the skin barrier and the rapid depletion of essential fatty acids

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A

These were early-stage studies of BPC-157 as a cytoprotective agent for ulcerative colitis, and they were never completed to approval

Several animal studies have further shown that administration of GLP-1RAs, before or shortly after experimentally-induced stroke, increased angiogenesis, neurogenesis and cerebral blood flow (CBF), reduced neuroinflammation, oxidative stress, excitotoxicity, BBB leakage and apoptosis, and induced dose-dependent decreases in infarct volume [60,61,62]

At Vive Ageless Weight Loss Center, Rafael Olartecoechea offers effective medical weight loss programs

Tolentino MJ, Miller JW, Gragoudas ES, et al